scorecard

You Searched For "cipla gilead" and got 20 results


Sort By:


Business Insider Latest Story Image
2 mins read

Cipla signs licensing agreement with Gilead to manufacture and sell antiviral drug remdesivir

Leading pharmaceutical company Cipla on Wednesday announced it has signed a non-exclusive licensing…

Business Insider Latest Story Image
1 min read

Cipla inks licensing pact with Gilead Sciences for potential COVID-19 treatment drug remdesivir

The EUA is based on available data from two global clinical trials – US National Institute for All…

PTI   


Business Insider Latest Story Image
2 mins read

FDA warns against co-administration of remdesivir with CQ or HCQ for COVID-19 patients

Following an evaluation of the emergency use authorization criteria and scientific evidence a…

PTI   


Business Insider Latest Story Image
1 min read

Cipla launches generic remdesivir for COVID-19 patients

Commenting on the launch, Cipla Ltd MD and Global CEO Umang Vohra said, "Cipla appreciates the stro…

PTI   


Business Insider Latest Story Image
4 mins read

Cipla, Zydus Cadila, Jubilant Life and Dr Reddy’s shares gain after FDA approves Remdesivir for treating COVID-19 patients

The shares of pharma major Cipla, Zydus Cadila, Jubilant Life Sciences and Dr Reddy Labs gained dur…

Business Insider Latest Story Image
3 mins read

Top stock movers — Tata Motors, SBI Cards, Cochin Shipyard, Zydus Cadila, Cipla, Dr Reddy’s, MphasiS, and others

Indian stock market indices opened on a higher note on Friday, tracking gains in index majors HDFC …

Business Insider Latest Story Image
2 mins read

Top stocks to watch — Cipla, Zydus Cadila, Dr Reddy Laboratories, Tech Mahindra, Avenue Supermarts, Cochin Shipyard, and others

Amidst mixed cues from the global markets, the Indian equities are likely to open flat on Friday. T…

Business Insider Latest Story Image
3 mins read

These are the companies that are making Remdesivir in India

Dr Reddy’s Lab is the sixth pharmaceutical company to introduce Remdesiv…

Business Insider Latest Story Image
2 mins read

Cipla to sell anti-viral drug remdesivir as Cipremi in India

In May, US drug maker Gilead Sciences extended a voluntary non-exclusive license to Cipla to man…

Business Insider Latest Story Image
2 mins read

Cipla says COVID-19 drug Remdesivir will hit market this week

As India faces a shortage of Covid-19 drug Remdesivir, the pharmaceutical company Cipla said it wil…

Business Insider Latest Story Image
3 mins read

Wanted! American asks for ‘Made in India’ hepatitis drug for just 1% of its cost

Know what he planned to secure the drug for US citizens and hurdles involved in it. But there was …

Business Insider Latest Story Image
2 mins read

COVID-19: Hetero, Cipla get nod to manufacture, market antiviral drug remdesivir

This comes a day after the Drug Controller General of India (DCGI), considering the emergency and u…

PTI   


Business Insider Latest Story Image
1 min read

Cipla shares gain over 3 pc as co launches generic remdesivir for COVID-19 patients

Remdesivir is the only USFDA-approved EUA for treatment for adult and paediatric patients hospitali…

PTI   


Business Insider Latest Story Image
2 mins read

US secures almost entire world stock of Covid-19 drug remdesivir from Gilead Sciences for the next three months

As a result of an agreement with the drug maker announced earlier this week, the US Department …

Business Insider Latest Story Image
1 min read

Cipla to price generic version of COVID-19 drug remdesivir at less than Rs 5,000 per vial

Cipla has been granted regulatory approval by the Drug Controller General of India (DCGI) for rest…

PTI   


Business Insider Latest Story Image
2 mins read

These are the companies manufacturing COVID-19 drug Remdesivir in India

The agreements allow these companies to manufacture remdesivir for distribution in 127 count…

Business Insider Latest Story Image
2 mins read

These are the companies that are making Remdesivir in India

Zydus Cadila has launched Remdesivir under the brand name Remdac, used to treat patients sufferin…

Business Insider Latest Story Image
3 mins read

₹10,000 invested in Biocon just before lockdown is now worth over ₹16,500⁠— here’s why

Indian pharmaceutical giant Biocon Limited on July 11 got approved from the Drugs Controller Genera…

Business Insider Latest Story Image
3 mins read

Remdesivir, Favipiravir antiviral drugs 'no game changers' in COVID fight, say medical experts

Commenting on the launch, Cipla Ltd MD and Global CEO Umang Vohra said, "Cipla appreciates the stro…

PTI   


Business Insider Latest Story Image
3 mins read

Remdesiver, Favipiravir antiviral drugs 'no game changers' in COVID fight, say medical experts

Commenting on the launch, Cipla Ltd MD and Global CEO Umang Vohra said, "Cipla appreciates the stro…

PTI